Sixteen Major Drugmakers Agree to U.S. Price Parity, Commit to Direct Sales via TrumpRx.gov
Sixteen large pharmaceutical companies have publicly agreed to align U.S. prescription drug prices with levels charged in other developed nations, accept most-favoured-nation pricing, sell medicines directly to consumers through a new federal platform called TrumpRx.gov and commit to substantial U.S. investments. These deals follow letters sent by …